| Quantity | 20 nmol, 50 nmol, 100 nmol, 200 nmol | ~0.6x10^6 cells per 1ml of freezing medium (vial) | 2 vials | 1mg | 20 nmol, 50 nmol, 100 nmol, 200 nmol |
| Description | The product SIRGT29950WQ-LNA is a type of small interfering RNA (siRNA) that targets TXNL1 gene and regulates the expression of gene. The siRNA interferes with the expression of TXNL1 gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. The The product SIRGT29950WQ-LNA is a type of small interfering RNA (siRNA) that targets TXNL1 gene and regulates the expression of gene. The siRNA interferes with the expression of TXNL1 gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. The siRNA is systematically modified with the synthetic RNA-like high affinity nucleotide analogue, Locked Nucleic Acid (LNA), to improve its bio-stability, specificity and efficiency. It has potential applications in RNA interference (RNAi) and gene therapy development.... Read More | iNeu™ human dopaminergic neurons are derived from human dermal cells using a non-integrated induced pluripotent stem cell (iPSC) line under fully defined proprietary induction and maturation conditions. iNeu™ cells are plated in a monolayer when cultured, are branched, and express iNeu™ human dopaminergic neurons are derived from human dermal cells using a non-integrated induced pluripotent stem cell (iPSC) line under fully defined proprietary induction and maturation conditions. iNeu™ cells are plated in a monolayer when cultured, are branched, and express biomarkers such as beta3-Tuj (neurons), tyrosine hydroxylase (TH) and dopamine transporter (DAT). iNeu™ can be used under mature conditions, co-culture conditions (used with astrocytes or other neuronal subtypes), and short-term functional characterization studies.... Read More | Creative Biolabs offers a range of recombinant cell lines for Immunotherapy discovery and development. | This product is a 93.2 kDa Human SLC13A3 membrane protein expressed in In vitro wheat germ expression system with proprietary liposome technology. The protein is for research use only and is not approved for use in humans or in clinical diagnosis. | The product SIRGT41440WQ-2OMe is a type of small interfering RNA (siRNA) that targets HRASLS2 gene and regulates the expression of gene. The siRNA interferes with the expression of HRASLS2 gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. TheThe product SIRGT41440WQ-2OMe is a type of small interfering RNA (siRNA) that targets HRASLS2 gene and regulates the expression of gene. The siRNA interferes with the expression of HRASLS2 gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. The siRNA is designed with 2_-O-methyl (2'-OMe) modification to provide increased stability, increased specificity and reduced immunogenicity. It has potential applications in RNA interference (RNAi) and gene therapy development.... Read More |